MedTrace Logo

Large Cell Lymphoma Pilot Study III

NCT00187070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2008-05-07

No results posted yet for this study

Summary

The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes an intensification phase with hematopoietic stem cell support for children with large cell lymphoma

Conditions

  • Lymphoma, Large Cell
  • Lymphoma, Non-Hodgkin

Interventions

DRUG

Doxorubicin, Cotrimoxazole, Carboplatin, Ifosfamide, Dexamethasone, Prednisone, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Vinblastine

See Detailed Description section for details of treatment interventions.

PROCEDURE

Stem cell transplant,

See Detailed Description section for details of treatment interventions.

RADIATION

Radiation Therapy

See Detailed Description section for details of treatment interventions.

Sponsors & Collaborators

Principal Investigators

  • John T. Sandlund, M.D. · St. Jude Children's Research Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-12-31
Primary Completion
2001-07-31
Completion
2001-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00187070 on ClinicalTrials.gov